Financhill
Buy
60

MET Quote, Financials, Valuation and Earnings

Last price:
$81.09
Seasonality move :
-0.32%
Day range:
$80.78 - $81.57
52-week range:
$65.21 - $88.09
Dividend yield:
2.77%
P/E ratio:
15.26x
P/S ratio:
0.77x
P/B ratio:
1.85x
Volume:
1.2M
Avg. volume:
3.6M
1-year change:
-1.46%
Market cap:
$53.4B
Revenue:
$71B
EPS (TTM):
$5.31

Earnings Data

Next earnings date for MET
Feb 04
2026
Most recent earnings per share
$1.22
Missed by $1.10
(Nov 5/2025)
Consensus Estimate
$2.32
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MET Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $31.4B -- -- $2.36 --
11/05/2025 Q3 $18.7B $17.4B $1.22 $2.32 -$1.10
08/06/2025 Q2 $18.5B $17.3B $1.03 $2.16 -$1.13
04/30/2025 Q1 $18.1B $18.6B $1.28 $2.01 -$0.73
02/05/2025 Q4 $19.5B $18.7B $1.78 $2.09 -$0.32
10/30/2024 Q3 $18.4B $18.4B $1.81 $2.18 -$0.37
07/31/2024 Q2 $18.6B $17.8B $1.28 $2.11 -$0.83
05/01/2024 Q1 $17.7B $16.1B $1.10 $1.82 -$0.72
02/01/2024 Q4 $18.2B $19B $0.77 $1.91 -$1.13
11/01/2023 Q3 -- $15.9B $0.56 -- --
08/02/2023 Q2 -- $16.6B $0.48 -- --
05/03/2023 Q1 -- $15.4B $0.02 -- --
02/01/2023 Q4 -- $15.6B $1.96 -- --
11/02/2022 Q3 -- $22.3B $1.37 -- --
08/03/2022 Q2 -- $15.5B $1.08 -- --
05/04/2022 Q1 -- $15.4B $1.89 -- --
02/02/2022 Q4 -- $20.1B $1.39 -- --
11/03/2021 Q3 -- $16.9B $1.77 -- --
08/04/2021 Q2 -- $18.5B $3.83 -- --
05/05/2021 Q1 -- $15.6B $0.33 -- --
02/03/2021 Q4 -- $19.4B $0.14 -- --
11/04/2020 Q3 -- $16B $0.69 -- --
08/05/2020 Q2 -- $14.1B $0.07 -- --
05/06/2020 Q1 -- $18.3B $4.75 -- --
02/05/2020 Q4 -- $17.1B $0.58 -- --
10/30/2019 Q3 -- $18.7B $2.30 -- --
07/31/2019 Q2 -- $17.5B $1.77 -- --
05/01/2019 Q1 -- $16.3B $1.40 -- --
02/06/2019 Q4 -- $15.7B $2.04 -- --
11/01/2018 Q3 -- $16.3B $0.88 -- --
08/01/2018 Q2 -- $21.2B $0.83 -- --
05/02/2018 Q1 -- $14.8B $1.19 -- --
01/31/2018 Q4 -- $16B $2.20 -- --
11/01/2017 Q3 -- $16.2B -$0.09 -- --
08/02/2017 Q2 -- $15.3B $0.80 -- --
05/03/2017 Q1 -- $15B $0.79 -- --
02/02/2017 Q4 -- $12.8B -$1.89 -- --
11/02/2016 Q3 -- $15.8B $0.51 -- --
08/03/2016 Q2 -- $15.2B $0.06 -- --
05/04/2016 Q1 -- $18.4B $1.98 -- --
02/04/2016 Q4 -- $17B $0.70 -- --

MetLife, Inc. Earnings Questions

  • How Much did MetLife, Inc. Generate in Revenue Last Quarter?

    MetLife, Inc. reported $17.4B worth of top line sales in its most recent quarter.

  • Did MetLife, Inc. Beat Earnings Last Quarter?

    MetLife, Inc. announced earnings per share of $1.22 which represents a miss of analyst forecast a $2.32 per share.

  • Is MetLife, Inc. Profitable?

    MetLife, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for MetLife, Inc. EPS Next Year?

    MetLife, Inc.'s earnings are forecast to grow from $5.94 per share to $8.18 per share next year representing an increase of 46.63%.

  • When is MetLife, Inc.'s Earnings Date?

    MetLife, Inc.'s next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock